126 related articles for article (PubMed ID: 35282475)
1. ABO BLOOD GROUP GENOTYPES IN WOMEN WITH BREAST CANCER.
Bezek T; Bingulac-Popović J; Bagatin D; Petlevski R; Jukić I
Acta Clin Croat; 2022 Feb; 60(3):354-360. PubMed ID: 35282475
[TBL] [Abstract][Full Text] [Related]
2. ABO and Rh blood groups frequency in women with HER2 positive breast cancer.
Urun Y; Utkan G; Altundag K; Arslan O; Onur H; Arslan UY; Kocer M; Dogan I; Senler FC; Yalcin B; Demirkazik A; Akbulut H; Icli F
J BUON; 2012; 17(3):457-60. PubMed ID: 23033281
[TBL] [Abstract][Full Text] [Related]
3. Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study.
Rummel S; Shriver CD; Ellsworth RE
BMC Med Genet; 2012 May; 13():41. PubMed ID: 22642827
[TBL] [Abstract][Full Text] [Related]
4. ABO blood groups and genetic risk factors for thrombosis in Croatian population.
Jukic I; Bingulac-Popovic J; Dogic V; Babic I; Culej J; Tomicic M; Vuk T; Sarlija D; Balija M
Croat Med J; 2009 Dec; 50(6):550-8. PubMed ID: 20017223
[TBL] [Abstract][Full Text] [Related]
5. Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort.
Klimant E; Glurich I; Mukesh B; Onitilo AA
Clin Med Res; 2011 Nov; 9(3-4):111-8. PubMed ID: 21263059
[TBL] [Abstract][Full Text] [Related]
6. Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.
Liu XY; Ma D; Xu XE; Jin X; Yu KD; Jiang YZ; Shao ZM
Theranostics; 2018; 8(22):6386-6399. PubMed ID: 30613307
[TBL] [Abstract][Full Text] [Related]
7. ABO blood type/Rh factor and the incidence and outcomes for patients with triple-negative breast cancer.
Yu J; Gao F; Klimberg VS; Margenthaler JA
Ann Surg Oncol; 2012 Oct; 19(10):3159-64. PubMed ID: 22878611
[TBL] [Abstract][Full Text] [Related]
8. Use of maternal plasma for non-invasive prenatal diagnosis of fetal ABO genotypes.
Meng JL; Wang XT; Wang Y; Yue YF; Wang X; Chen ZJ
Clin Chem Lab Med; 2007; 45(8):981-6. PubMed ID: 17867986
[TBL] [Abstract][Full Text] [Related]
9. SERUM THYROTROPIN CONCENTRATIONS ARE NOT PREDICTIVE OF AGGRESSIVE BREAST CANCER BIOLOGY IN EUTHYROID INDIVIDUALS.
Villa NM; Li N; Yeh MW; Hurvitz SA; Dawson NA; Leung AM
Endocr Pract; 2015 Sep; 21(9):1040-5. PubMed ID: 26121443
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Estrogen receptors, Progesterone receptors and HER2-neu immunohistochemistry results in breast cancer with those of Oncotype Dx.
Sughayer MA; Alhassoon S; Sughayer HM
Ann Diagn Pathol; 2020 Aug; 47():151556. PubMed ID: 32592992
[TBL] [Abstract][Full Text] [Related]
11. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
Badowska-Kozakiewicz A; Sobol M; Patera J
Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
[TBL] [Abstract][Full Text] [Related]
12. Concordance of breast cancer biomarker status between routine immunohistochemistry/in situ hybridization and Oncotype DX qRT-PCR with investigation of discordance, a study of 591 cases.
Sechrist H; Glasgow A; Bomeisl P; Gilmore H; Harbhajanka A
Hum Pathol; 2020 Oct; 104():54-65. PubMed ID: 32758491
[TBL] [Abstract][Full Text] [Related]
13. Association between GSTP1 genotypes and hormone receptor phenotype in invasive ductal carcinomas of breast.
Khabaz MN; Gari MA; Al-Maghrabi JA; Nedjadi T; Bakarman M
Asian Pac J Cancer Prev; 2015; 16(5):1707-13. PubMed ID: 25773813
[TBL] [Abstract][Full Text] [Related]
14. Assessment of topoisomerase II-alpha gene status by dual color chromogenic
Neama RAA; Habib MA; Ali SA; Al-Khafaji AH; Alqanbar MF
Indian J Pathol Microbiol; 2017; 60(4):475-480. PubMed ID: 29323058
[TBL] [Abstract][Full Text] [Related]
15. Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
Yoon HJ; Kang KW; Chun IK; Cho N; Im SA; Jeong S; Lee S; Jung KC; Lee YS; Jeong JM; Lee DS; Chung JK; Moon WK
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1534-43. PubMed ID: 24652232
[TBL] [Abstract][Full Text] [Related]
16. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania.
Pajenga E; Rexha T; Çeliku S; Ugrinska A; Bejtja G
Cent Eur J Public Health; 2016 Sep; 24(3):171-175. PubMed ID: 27760283
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.
Shukla S; Singh BK; Pathania OP; Jain M
Indian J Med Res; 2016 May; 143(Supplement):S52-S58. PubMed ID: 27748278
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
Saltzman BS; Malone KE; McDougall JA; Daling JR; Li CI
Breast Cancer Res Treat; 2012 Oct; 135(3):849-55. PubMed ID: 22903686
[TBL] [Abstract][Full Text] [Related]
20. ABO blood groups and psychiatric disorders: a Croatian study.
Pisk SV; Vuk T; Ivezić E; Jukić I; Bingulac-Popović J; Filipčić I
Blood Transfus; 2019 Jan; 17(1):66-71. PubMed ID: 29517969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
